Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer - A review

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 6, 2006, Pages 1061-1077

  Proia, Nicole K ^a   Paszkiewicz, Geraldine M ^a   Nasca, Maureen A Sullivan ^a   Franke, Gail E ^a   Pauly, John L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CANTHAXANTHIN; CARCINOGEN; RETINOL; RIBOFLAVIN; TUMOR MARKER; ZINC;

BACTERIUM ADHERENCE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RESEARCH; CANCER SCREENING; CARCINOGEN DNA INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CHEEK; CHEMOPROPHYLAXIS; CHROMOSOME ABERRATION; CLINICAL TRIAL; CYTOLOGY; DNA ADDUCT; DNA DAMAGE; DNA POLYMORPHISM; ESOPHAGUS INJURY; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LEUKOPLAKIA; MALIGNANT NEOPLASTIC DISEASE; MICRONUCLEUS; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOKELESS TOBACCO; SMOKING;

HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; MUTATION; SMOKING; TOBACCO, SMOKELESS;

EID: 33745698098     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0983     Document Type: Review

References (137)

1. World Cancer Report. In: Stewart BW, Kleihues P, editors. Lyon (France): IARC Press; 2003. 3251 pp.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 83. Tobacco smoke and involuntary smoking. Lyon (France): IARC; 2004. p. 1452.
4. DeMarini MD. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004;567:447-74.
5. Taybos G. Oral changes associated with tobacco use. Am J Med Sci 2003;326:179-82.
6. Silverman S. Oral cancer. 5th ed. American Cancer Society. Hamilton (Ontario, Canada): BC Decker, Inc.; 2003. p. 212.
7. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancers. Nat Rev Cancer 2003;3:733-44.
8. Bonassi S, Ugolini D, Kirsch-Volders M, Stromberg U, Vermeulen R, Tucker JD. Human population studies with cytogenic biomarkers: review of the literature and future prospectives. Environ Mol Mutagen 2005;45:257-70.
9. Maruvada P, Wang W, Wagner PD, Srivastava S. Biomarkers in molecular medicine: cancer detection and diagnosis. BioTechniques 2005;38:S9-15.
10. Scaros O, Fisler R. Biomarker technology roundup: from discovery to clinical applications, a broad set of tools is required to translate from the lab to the clinic. BioTechniques 2005;38:S30-2.
11. Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey 1988-1994. J Am Dent Assoc 2004;135:1279-86.
12. Bloching M, Hofmann A, Lautenschlager C, Bergaus A, Grummt T. Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol 2000;23:550-5.
13. Majer BJ, Laky B, Knasmüller S, Kassie F. Use of the micronucleus assay with exfoliated epithelial cells as a biomarker for monitoring individuals at elevated risk of genetic damage and in chemoprevention trials. Mutat Res 2001;489:147-72.
14. DeFlora S, D'Agostini F, Balansky R, et al. Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis. Mutat Res 2003;523-4:237-52.
15. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P. Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ 2005;69:255-65.
16. Cruz GD, Ostroff JS, Kumar JV, Gajendra S. Preventing and detecting oral cancer. Oral health care providers' readiness to provide health behavior counseling and oral cancer examinations. J Am Dent Assoc 2005;136:594-601.
17. De Veld DCG, Witjes MJH, Sterenborg HJCM, Roodenburg JLN. The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 2005;41:117-31.
18. Chang C-J, Wilder-Smith P. Topical application of Photofrin for photodynamic diagnosis of oral neoplasms. Plast Reconstr Surg 2005;115:1877-86.
19. Skala MC, Squirrel JM, Vrotosos KM, et al. Multiphoton microscopy of endogenous fluorescence differentiates normal, precancerous, and cancerous squamous epithelial tissue. Cancer Res 2005;65:1180-6.
20. Mashberg A. Tolonium (toluidine blue) rinse-a screening method for recognition of squamous carcinoma. Continuing study of oral cancer. IV. JAMA 1981;245:2408-10.
21. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:535-40.
22. Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65:8017-21.
23. Bonassi S, Fenech M, Lando C, et al. Human MicroNucleus Project: international database comparison for results with cytokinesis-block micronucleus assay in human lymphocytes. I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 2001;37:31-45.
24. Bonassi S, Neri M, Lando C, et al. Effect of smoking on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus Project. Mutat Res 2003;543:155-66.
25. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong generic susceptibility markers for bladder cancer. Carcinogenesis 2005;26:1263-71.
26. Koppikar P, deVilliers E-M, Mulherkar R. Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 2005;113:946-50.
27. Belowska J, Fraczek A, Ral M, et al. Preliminary study on the frequency of micronuclei in buccal mucosa cells sampled from patients with tumors of the larynx [in Polish]. Prezgl Lek 2004;61:248-50.
28. Wu PA, Loh CH, Hsieh LL, Liu TY, Chen CJ, Liou SH. Clastogenic effect for cigarette smoking but not areca quid chewing as measured by micronuclei in exfoliated buccal mucosa cells. Mutat Res 2004;562:27-38.
29. Orellana-Bustos AI, Espinoza-Santander IL, Franco-Martinez E, Lobos-James-Freyre N, Ortega-Pinto AV. Evaluation of keratinization and AgNORs count in exfoliative cytology of normal oral mucosa from smokers and non-smokers. Med Oral 2004;9:197-203.
30. Spivack SD, Hurteau GJ, Jain R, et al. Gene-environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res 2004;64:6805-13.
31. Suhas S, Ganapathy KS, Gayatri Devi M, Ramesh C. Application of the micronucleus test to exfoliated epithelial cells from the oral cavity of beedi smokers, a high risk group for oral cancer. Mutat Res 2004;651:15-21.
32. Moore LE, Wienche JK, Bates MN, Zheng S, Rey OA, Smith AH. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 2004;211:199-207.
33. Montero R, Serrano L, Davila V, et al. Metabolic polymorphisms and the micronucleus frequency in buccal epithelium of adolescents living in an urban environment. Environ Mol Mutagen 2003;42:216-22.
34. Konopacka M. Effect of smoking and aging on micronucleus frequencies in human exfoliated buccal cells. Neoplasma 2003;50:380-2.
35. Elahi A, Bendaly J, Zheng Z, et al. Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer 2003;98:872-80.
36. Elahi A, Zhong Z, Park J, Eyring K, McCaffery T, Lazarus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002;23:1229-34.
37. Gordon AE, El Ahmer OR, Chan R, et al. Why is smoking a risk factor for sudden infant death syndrome? Child Care Health Dev 2002;28:23-5.
38. Zhang Y, Chen SY, Hsu T, Santella R. Immunohistochemical detection of malondialdehyde-DNA adducts in human oral mucosa cells. Carcinogenesis 2002;23:207-11.
39. Phillips DH. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002;23:1979-2004.
40. Morabia A, Bernstein MS, Bouchardy I, Kurtz J, Morris MA. Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol 2000;152:226-32.
41. Sweeney C, Farrow DC, Schwartz SM, Eaton DL, Checkoway H, Vaughan TL. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case control study. Cancer Epidemiol Biomarkers Prev 2000;9:449-54.
42. El Ahmer OR, Essery SD, Saadia AT, et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol 1999;23:27-36.
43. Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc Soc Exp Biol Med 1999;220:218-24.
44. Barrera JE, Ai H, Pan Z, Meyers AD, Varella-Garcia M. Malignancy detection by molecular cytogenetics in clinically normal mucosa adjacent to head and neck tumors. Arch Otolaryngol Head Neck Surg 1998;124:847-51.
45. Liede KE, Alfthan G, Hietanen JHP, Haukka JK, Saxen LM, Heinonen OP. β-Carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long term β-carotene supplementation in male smokers. Eur J Clin Nutr 1998;52:872-6.
46. Hsu TM, Zhang YJ, Stantella R. Immunoperoxidase quantitation of 4-aminobiphenly- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1997;6:193-9.
47. 6-methylguanine-DNA methyltransferase activity in human buccal mucosal tissue and cell cultures. Complex mixtures related to habitual use of tobacco and betel quid inhibit the activity in vitro. Carcinogenesis 1997;18:1889-95.
48. Stone J, Jones N, McGregor A, Waters R. Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa versus biopsies. Cancer Res 1995;55:1267-70.
49. Zhang Y, Hsu TM, Santella R. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 1995;4:133-8.
50. Piatti G, Gazzola T, Allegra L. Bacterial adherence in smokers and non-smokers. Pharm Res 1997;36:481-4.
51. Rojas E, Valverde M, Sordo M, Ostrosky-Wegman P. DNA damage in exfoliated buccal cells of smokers assessed by the single cell gel electrophoresis assay. Mutat Res 1996;370:115-20.
52. Benner SE, Wargovich MJ, Lippman SM, et al. Reduction in oral mucosa micronuclei frequency following α-tocopherol treatment in oral leukoplakia. Cancer Epidemiol Biomarkers Prev 1994;3:73-6.
53. Piyathilake CJ, Macaluso M, Hine RJ, Vinter DW, Richards EW, Krumdieck CL. Cigarette smoking, intracellular vitamin deficiency, and occurrence of micronuclei in epithelial cells of the buccal mucosa. Cancer Epidemiol Biomarkers Prev 1995;4:751-8.
54. Stich HF, Dunn BP. DNA adducts, micronuclei and leukoplakias as intermediate endpoints in intervention trials. IARC Sci Publ 1988;89:137-45.
55. Niederman MS, Rafferty TD, Sasaki CT, Merrill WW, Matthay RA, Reynolds HY. Comparison of bacterial adherence to ciliated and squamous epithelial cells obtained from the human respiratory tract. Am Rev Respir Dis 1983;127:85-90.
56. Stich HF, Rosin P. Quantitating the synergistic effect of smoking and alcohol consumption with the micronucleus test on human buccal mucosa cells. Int J Cancer 1983;31:305-8.
57. Besarati Nia A, Van Straaten HWM, Godschalk RWL, et al. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in mouth floor and buccal mucosa cells of smokers and nonsmokers. Environ Mol Mutagen 2000;36:127-33.
58. Romano G, Sgambato A, Boninsegna AG, et al. Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay. Cancer Epidemiol Biomarkers Prev 1999;8:91-6.
59. Romano G, Mancini R, Fedele P, et al. Immunohistochemical analysis of 4-aminobiphenyl-DNA adducts in oral mucosa cells of smokers and nonsmokers. Anticancer Res 1997;17:2827-30.
60. Oßwald K, Mittas A, Glei M, Pool-Zobel BL. New revival of an old biomarker: characterization of buccal cells and determination of genetic damage in the isolated fraction of viable leucocytes. Mutat Res 2003;544:321-9.
61. Munoz N, Hayashi M, Bang LJ, Wahrendorf J, Crespi M, Bosch FX. Effect of riboflavin, retinol and zinc on micronuclei of buccal mucosa and of esophagus: a randomized double-blind intervention study in China. J Natl Cancer Inst 1987;79:687-91.
62. Sarto F, Finotto S, Giacomelli L, Mazzotti D, Tomanin R, Levis AG. The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis 1987;2:11-7.
63. Wrubel JW, Scopp IW. A study of the exfoliative cytology of the hard palate and buccal mucosa following cessation of smoking in previous smokers. J Dent Res 1961;40:341-5.
64. Goral V, Culbreth W, Green C, Nelms T, Truax K. A cytologic study of oral mucosal cell alterations in smokeless tobacco users and efficacy of a related cessation program. J Den Hyg 1999;73:5-12.
65. Ramaesh T, Mendis BR, Ratnatunga N, Thattil RO. The effect of tobacco smoking and of betel chewing with tobacco on the buccal mucosa: a cytomorphometric analysis. J Oral Pathol Med 1999;28:385-8.
66. Ozkul Y, Donmez H, Erenmemisoglu A, Demirtas H, Imamoglu N. Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users. Mutagenesis 1997;12:285-7.
67. Roberts DM. Comparative cytology of the oral cavities of snuff users. Acta Cytol 1997;41:1008-14.
68. Desai SS, Ghaisas SD, Jakhi SD, Bhide SV. Cytogenetic damage in exfoliated oral mucosal cells and circulating lymphocytes of patients suffering from precancerous oral lesions. Cancer Lett 1996;109:9-14.
69. Ghose UR, Parida BB. Cytological study of exfoliated buccal mucosa cells of tribes in Orissa State (India) with high risk for oral cancer. Indian J Cancer 1995;32:95-9.
70. Kayal JJ, Trivedi AH, Dave BJ, et al. Incidence of micronuclei in oral mucosa of users of tobacco products singly or in various combinations. Mutagenesis 1993;8:31-3.
71. Stich HF, Parida BB, Brunnemann KD. Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of "reverse" smokers, Khaini-tobacco chewers and gudakhu users. Int J Cancer 1992;50:172-6.
72. Das RK, Dash BC. Genotoxicity of "gudakhu," a tobacco preparation. II. In habitual users. Food Chem Toxicol 1992;30:1045-9.
73. Dave BJ, Trivedi AH, Adhvaryu SG. Role of areca nut consumption in the cause of oral cancers a cytogenetic assessment. Cancer 1992;70:1017-23.
74. Adhvaryu SG, Dave BJ, Trivedi AH. Cytogenetic surveillance of tobacco-areca nut (mava) chewers, including patients with oral cancers and premalignant conditions. Mutat Res 1991;261:41-9.
75. Dave BJ, Trivedi AH, Adhvaryu SG. Cytogenetic studies reveal increased genomic damage among "pan masala" consumers. Mutagenesis 1991;6:159-63.
76. Nair U, Obe G, Nair J, et al. Evaluation of frequency of micronucleated oral mucosa cells as a marker for genotoxic damage in chewers of betel quid with and without tobacco. Mutat Res 1991;261:163-8.
77. Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: a field test in snuff users. J Epidemiol 1991;134:840-50.
78. Livingston GK, Reed RN, Olson BL, Lockey JE. Induction of nuclear aberrations by smokeless tobacco in epithelial cells of human oral mucosa. Environ Mol Mutagen 1990;15:136-44.
79. Stich HF, Rosin MP, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. Remission or oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with β-carotene and with β-carotene plus vitamin A. Int J Cancer 1988;42:195-9.
80. Stich HF, Hornby AP, Dunn BP. A pilot β-carotene intervention trial with Inuits using smokeless tobacco. Int J Cancer 1985;36:321-7.
81. Stich HF, Rosin MP. Towards a more comprehensive evaluation of a genotoxic hazard in man. Mutat Res 1985;150:43-50.
82. Stich HF, Stich W, Rosin MP, Vallejera MO. Use of the micronucleus test to monitor the effect of vitamin A, β-carotene and canthaxanthin on the buccal mucosa of betel nut/tobacco chewers. Int J Cancer 1984;34:745-50.
83. Stich HF, Rosin MP, Vallejera MO. Reduction with vitamin A and β-carotene administration of proportion of micronucleated buccal mucosal cells in Asian betel nut and tobacco chewers. Lancet 1984;1:1204-6.
84. Stich HF, Rosin MP. Micronuclei in exfoliated human cells as an internal dosimeter for exposures to carcinogens. In: Stich HF, editor. Carcinogens and mutagens in the environment. Boca Raton (FL): CRC Press; 1983. p. 17-25.
85. Stich HF, Stich W, Parida BB. Elevated frequency of micronucleated cells in the buccal mucosa of individuals at high risk for oral cancer: betel quid chewers. Cancer Lett 1982;17:125-34.
86. Stich HF, Curtis JR, Parida BB. Application of the micronucleus test to exfoliated cells of high cancer risk groups: tobacco chewers. Int J Cancer 1982;30:553-9.
87. Mager DL, Haffajee AD, Norris PM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Trans Med 2005;3:27.
88. Lopez M, Aguirre JM, Cuevasy N, Anzolay M, Videgainz J, Aguirregaviriaz J. Use of cytological specimens for p53 gene alteration detection in oral squamous cell carcinoma risk patients. J Clin Oncol 2004;16:366-70.
89. Cheng B, Rhodus NL, Williams B, Griffin RJ. Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:465-70.
90. Maraki D, Becker J, Boecking A. Cytologic and DNA-cytometric very early diagnosis of oral cancer. J Oral Pathol Med 2004;33:398-404.
91. Ramirez A, Saldanha PH. Micronucleus investigation of alcoholic patients with oral cancer. Genet Mol Res 2002;1:246-60.
92. Casartelli G, Bonotti S, De Ferrari M, et al. Micronucleus frequencies in exfoliated buccal cells of normal mucosa, precancerous lesions and squamous cell carcinoma. Anal Quant Cytol Histol 2000;22:486-92.
93. van Oijen MGCT, Gilsing MMA, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol 1998;34:297-303.
94. Babu S, Bhat RV, Kumar PU, et al. A comparative clinico-pathological study of oral submucous fibrosis in habitual chewers of pan masala and betel quid. J Toxicol Clin Toxicol 1996;34:317-20.
95. Marchand LL, Lum-Jones A, Saltzman B, Visaya V, Nomura AMY, Kolonel LN. Feasibility of collecting buccal cell DNA by mail in a cohort study. Cancer Epidemiol Biomarkers Prev 2001;10:701-3.
96. Garcia-Closas M, Egan KM, Abruzzo J, et al. Collection of genomic DNA from adults in epidemiological studies by buccal cell cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 2001;10:687-96.
97. Hayney MS, Dimanlig P, Lipsky JJ, Poland GA. Utility of a "swish and spit" technique for the collection of buccal cells for TAP haplotype determination. Mayo Clin Proc 1995;70:951-4.
98. Reshmi SC, Gollin SM. Chromosomal instability in oral cancer cells. J Dent Res 2005;84:107-17.
99. Reshmi SC, Gollin SM. Chromosomal instability and marker chromosome evolution oral squamous cell carcinoma. Genes Chromosomes Cancer 2004;41:38-46.
100. Saunders WS, Shuster M, Huang X, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A 2000;97:303-8.
101. Luo LZ, Werner KM, Gollin SM, Saunders WS. Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells. Mutat Res 2004;554:375-85.
102. Evans HJ, Neary GJ, Williamson F. The relative biological efficiency of single doses of fast neutrons and γ-rays on Vicia faba roots and the effect of oxygen. Part II. Chromosome damage: the production of micronuclei. Int J Radiat Biol 1959;3:216-29.
103. Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat Res 1992;271:69-77.
104. von Ledebur M, Schmid W. The micronucleus test. Methodological aspects. Mutat Res 1973;19:109-17.
105. Schmid W. The micronucleus test. Mutat Res 1975;31:9-15.
106. Fenech M. The in vitro micronucleus technique. Mutat Res 2000;455:81-95.
107. Harty LC, Garcia-Closas M, Rothman N, Reid YA, Tucker MA, Hartge P. Collection of buccal cell DNA using treated cards. Cancer Epidemiol Biomarkers Prev 2000;9:501-6.
108. Boyle EC, Finlay BB. Bacterial pathogenesis: exploiting cellular adherence. Curr Opin Cell Biol 2003;15:633-9.
109. Fujiki H, Takeuchi H, Nishitani N, et al. Carcinogenic potential of tobacco tar-resistant Staphylococcus aureus in buccal cavity. J Cancer Res Clin Oncol 2004;130:301-5.
110. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
111. Vakkila J, Lotze MT. Inflammation and necrosis promote tumor growth. Nat Rev Immunol 2004;4:641-8.
112. Mignogna MD, Fedele S, LoRusso L, LoMuzio L, Bucci F. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004;40:120-30.
113. Larramendy L, Knuutila S. Increased frequency of micronuclei in B and T8 lymphocytes from smokers. Mutat Res 1991;259:189-95.
114. Ishikawa H, Tian Y, Yamauchi T. Influence of gender, age and lifestyle factors on micronuclei frequency in healthy Japanese populations. J Occup Health 2003;45:179-81.
115. DeFlora S, Izzotti A, D'Agostini F, et al. Induction and modulation of lung tumors: genomic and transcriptional alterations in cigarette smoke-exposed mice. Exp Lung Res 2005;31:19-35.
116. D'Agosini F, Balansky RM, Bennicelli C, Lubet RA, Kelloff GJ, DeFlora S. Pilot studies evaluating the lung tumor yield in cigarette smoke-exposed mice. Int J Oncol 2001;18:607-15.
117. Balansky RM, D'Agostini F, Izzotti A, DeFlora S. Less than additive interaction between cigarette smoke and chromium (VI) in inducing clastogenic damage in rodents. Carcinogenesis 2000;21:1677-82.
118. Chen S-Y. Effects of smokeless tobacco on the buccal mucosa of HMT rats. J Oral Pathol Med 1989;18:108-12.
119. Stich JE, Li KK, Chun Y-S, Weiss R, Park N-H. Effect of smokeless tobacco on the replication of herpes simplex virus in vitro and on production of viral lesions in hamster cheek pouch. Arch Oral Biol 1987;32:291-6.
120. Eipe N. The chewing of betel quid and oral submucous fibrosis and anesthesia. Anesth Analg 2005;100:1210-3.
121. Yang Y-H, Lien Y-C, Ho P-S, et al. The effects of chewing areca/betel quid with and without cigarette smoking on oral submucous fibrosis and oral mucosal lesions. Oral Dis 2005;11:88-94.
122. Chang Y-C, Hu C-C, Tseng T-H, et al. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J Oral Pathol Med 2001;30:458-64.
123. Sun LP, Li DZ, Liu ZM, et al. Analysis of micronuclei in the transferrin-receptor positive reticulocytes from peripheral blood of nasopharyngeal cancer patients undergoing radiotherapy by a single-laser flow cytometry. J Radiat Res (Tokyo) 2005;46:25-35.
124. Offer T, Ho E, Trabert MG, Bruno RS, Kuypers FA, Ames BN. A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J 2005;19:485-7.
125. Nüsse M, Marx K. Flow cytometric analysis of micronuclei in cell cultures and human lymphocytes: advantages and disadvantages. Mutat Res 1997;392:109-15.
126. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unraveling the immune system. Nat Rev Immunol 2004;4:648-55.
127. George TC, Basiji DA, Hall BE, et al. Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer. Cytometry 2004;59A:237-45.
128. National Toxicology Program, U.S. Department of Health and Human Services, 11th Report on Carcinogens. Available from: http://ntp.niehs.nih. gov/go/16183; 2005.
129. Carsballo RS, Giovino GA, Paychacek TF. Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine Tob Res 2004;6:19-25.
130. Perez-Stable EJ, Marin G, Marin BV, Benowitz NL. Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis 1992;145:53-7.
131. Lewis SJ, Cherry NM, Niven R, Barber PV, Wilde K, Povey AC. Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic. Biomarkers 2003;8:218-28.
132. Bramer SL, Kallungal BA. Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers 2003;8:187-203.
133. Xing S, Khanavkar B, Nakhosteen JA, Atay Z, Jöckel K-H, Marek W. Predictive value of image cytometry for diagnosis of lung cancer in heavy smokers. Eur Respir J 2005;25:956-63.
134. National Cancer Institute, U.S. Department of Health and Human Services. The Early Detection Research Network. Third Report. Srivastava S, Chief and Program Director; 2005. 96 pages.
135. WHO. IARC monograph on the evaluations of carcinogenic risks to humans. Vol. 83. Tobacco smoke and involuntary smoking. Lyon (France): IARC; 2004. p. 1452.
136. Hetch SS, Murphy SE, Carmella SG, et al. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev 2005;14:693-8.
137. Clearing the smoke-assessing the science base for tobacco harm reduction. In: Stratton K, Shetty P, Wallace R, Bondurant S, editors. Washington (DC): National Academy Press; 2001. p. 636.